MeSH D005901 - glaucoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Acetazolamide | Diamox | 1982-01-01 | |||
| Novast Laboratories | Acetazolamide | Acetazolamide | 2016-09-30 | |||
| Taro Pharmaceutical | Acetazolamide | Acetazolamide | 1997-05-28 | |||
| Mylan | Acetazolamide | Acetazolamide | 2012-05-09 | |||
| Chartwell Pharmaceuticals | Acetazolamide | Acetazolamide | 1982-01-01 | |||
| Ajanta Pharma | Acetazolamide | Acetazolamide | 2023-09-11 |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
50%11/22
Phase 2
82%14/17
Phase 3
63%25/40
Approved: 5Overall Success rate: 26%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use